首页> 外文期刊>American Journal of Surgical Pathology >Expression of the interferon regulatory factor 8/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker.
【24h】

Expression of the interferon regulatory factor 8/ICSBP-1 in human reactive lymphoid tissues and B-cell lymphomas: a novel germinal center marker.

机译:干扰素调节因子8 / ICSBP-1在人类反应性淋巴组织和B细胞淋巴瘤中的表达:一种新型生发中心标记。

获取原文
获取原文并翻译 | 示例
           

摘要

To assess the role of interferon regulatory factor (IRF) 8 in B-cell development and lymphomagenesis, we studied its expression in reactive lymphoid tissues, its relationship to other B-cell transcription factors, and its expression in a series of 232 B-cell tumors and 30 cell lines representing a variety of B-cell developmental stages. We found that although IRF8 was detectable in most reactive B-cells, its expression levels differed with developmental stage. Germinal center B cells contained the highest levels of IRF8, with lower levels seen in mantle and marginal zone B cells and none in plasma cells. IRF8 was coexpressed with PAX-5, Pu.1, and B-cell lymphoma (BCL)-6, and similar to BCL-6, was absent from the small population of IRF4-positive germinal center B cells thought to be committed to postgerminal center developmental programs. Similarly, IRF8 was most strongly expressed in lymphomas of germinal center origin with lower levels present in mantle cell lymphomas, chronic lymphocytic leukemia, and marginal zone lymphomas, and no expression observed in plasmacytic/plasmablastic neoplasms. The reciprocal expression pattern with IRF4 in reactive tissues was generally maintained in lymphomas with some exceptions. These results suggest an important role for IRF8 during germinal center B-cell development and in related lymphomas, and provide a new diagnostic marker helpful in distinguishing B-cell non-Hodgkin lymphoma subtypes.
机译:为了评估干扰素调节因子(IRF)8在B细胞发育和淋巴瘤发生中的作用,我们研究了其在反应性淋巴组织中的表达,与其他B细胞转录因子的关系以及在一系列232 B细胞中的表达肿瘤和代表各种B细胞发育阶段的30种细胞系。我们发现,尽管IRF8在大多数反应性B细胞中均可检测到,但其表达水平随发育阶段而有所不同。萌发的中心B细胞含有最高水平的IRF8,而在地幔和边缘区B细胞中则较低,浆细胞中则没有。 IRF8与PAX-5,Pu.1和B细胞淋巴瘤(BCL)-6共表达,并且与BCL-6类似,在少数IRF4阳性生发中心B细胞中缺失,该细胞被认为与生殖后生殖有关中心发展计划。同样,IRF8在生发中心起源的淋巴瘤中表达最强,在套细胞淋巴瘤,慢性淋巴细胞性白血病和边缘区淋巴瘤中含量较低,在浆细胞/浆母细胞瘤中未观察到表达。除某些例外,在淋巴瘤中通常维持反应性组织中IRF4的相互表达模式。这些结果表明IRF8在生发中心B细胞发育和相关淋巴瘤中的重要作用,并提供了有助于区分B细胞非霍奇金淋巴瘤亚型的新诊断标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号